Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Anti-Ageing Drugs Market Growth 2022-2028

  • LP 4844105
  • 93 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Anti-Ageing Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Anti-Ageing Drugs market size is USD million in 2022 from USD 80280 million in 2021, with a change of % between 2021 and 2022. The global Anti-Ageing Drugs market size will reach USD 135630 million in 2028, growing at a CAGR of 7.8% over the analysis period.

The United States Anti-Ageing Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Ageing Drugs market, reaching US$ million by the year 2028. As for the Europe Anti-Ageing Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Anti-Ageing Drugs players cover Nu Skin, BIOTIME, Elysium Health, and La Roche-Posay, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Ageing Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Hormonal Therapy

Antioxidants

Enzymes

Stem Cells

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Skin

Hair

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Nu Skin

BIOTIME

Elysium Health

La Roche-Posay

DermaFix

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Ageing Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-Ageing Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-Ageing Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti-Ageing Drugs Segment by Type

2.2.1 Hormonal Therapy

2.2.2 Antioxidants

2.2.3 Enzymes

2.2.4 Stem Cells

2.2.5 Others

2.3 Anti-Ageing Drugs Sales by Type

2.3.1 Global Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-Ageing Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-Ageing Drugs Sale Price by Type (2017-2022)

2.4 Anti-Ageing Drugs Segment by Application

2.4.1 Skin

2.4.2 Hair

2.4.3 Others

2.5 Anti-Ageing Drugs Sales by Application

2.5.1 Global Anti-Ageing Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-Ageing Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-Ageing Drugs Sale Price by Application (2017-2022)

3 Global Anti-Ageing Drugs by Company

3.1 Global Anti-Ageing Drugs Breakdown Data by Company

3.1.1 Global Anti-Ageing Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti-Ageing Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti-Ageing Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-Ageing Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti-Ageing Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti-Ageing Drugs Sale Price by Company

3.4 Key Manufacturers Anti-Ageing Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-Ageing Drugs Product Location Distribution

3.4.2 Players Anti-Ageing Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-Ageing Drugs by Geographic Region

4.1 World Historic Anti-Ageing Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-Ageing Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-Ageing Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti-Ageing Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-Ageing Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-Ageing Drugs Annual Revenue by Country/Region

4.3 Americas Anti-Ageing Drugs Sales Growth

4.4 APAC Anti-Ageing Drugs Sales Growth

4.5 Europe Anti-Ageing Drugs Sales Growth

4.6 Middle East & Africa Anti-Ageing Drugs Sales Growth

5 Americas

5.1 Americas Anti-Ageing Drugs Sales by Country

5.1.1 Americas Anti-Ageing Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti-Ageing Drugs Revenue by Country (2017-2022)

5.2 Americas Anti-Ageing Drugs Sales by Type

5.3 Americas Anti-Ageing Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-Ageing Drugs Sales by Region

6.1.1 APAC Anti-Ageing Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti-Ageing Drugs Revenue by Region (2017-2022)

6.2 APAC Anti-Ageing Drugs Sales by Type

6.3 APAC Anti-Ageing Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-Ageing Drugs by Country

7.1.1 Europe Anti-Ageing Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti-Ageing Drugs Revenue by Country (2017-2022)

7.2 Europe Anti-Ageing Drugs Sales by Type

7.3 Europe Anti-Ageing Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-Ageing Drugs by Country

8.1.1 Middle East & Africa Anti-Ageing Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-Ageing Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-Ageing Drugs Sales by Type

8.3 Middle East & Africa Anti-Ageing Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-Ageing Drugs

10.3 Manufacturing Process Analysis of Anti-Ageing Drugs

10.4 Industry Chain Structure of Anti-Ageing Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-Ageing Drugs Distributors

11.3 Anti-Ageing Drugs Customer

12 World Forecast Review for Anti-Ageing Drugs by Geographic Region

12.1 Global Anti-Ageing Drugs Market Size Forecast by Region

12.1.1 Global Anti-Ageing Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti-Ageing Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-Ageing Drugs Forecast by Type

12.7 Global Anti-Ageing Drugs Forecast by Application

13 Key Players Analysis

13.1 Nu Skin

13.1.1 Nu Skin Company Information

13.1.2 Nu Skin Anti-Ageing Drugs Product Offered

13.1.3 Nu Skin Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Nu Skin Main Business Overview

13.1.5 Nu Skin Latest Developments

13.2 BIOTIME

13.2.1 BIOTIME Company Information

13.2.2 BIOTIME Anti-Ageing Drugs Product Offered

13.2.3 BIOTIME Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BIOTIME Main Business Overview

13.2.5 BIOTIME Latest Developments

13.3 Elysium Health

13.3.1 Elysium Health Company Information

13.3.2 Elysium Health Anti-Ageing Drugs Product Offered

13.3.3 Elysium Health Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Elysium Health Main Business Overview

13.3.5 Elysium Health Latest Developments

13.4 La Roche-Posay

13.4.1 La Roche-Posay Company Information

13.4.2 La Roche-Posay Anti-Ageing Drugs Product Offered

13.4.3 La Roche-Posay Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 La Roche-Posay Main Business Overview

13.4.5 La Roche-Posay Latest Developments

13.5 DermaFix

13.5.1 DermaFix Company Information

13.5.2 DermaFix Anti-Ageing Drugs Product Offered

13.5.3 DermaFix Anti-Ageing Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 DermaFix Main Business Overview

13.5.5 DermaFix Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Anti-Ageing Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-Ageing Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hormonal Therapy

Table 4. Major Players of Antioxidants

Table 5. Major Players of Enzymes

Table 6. Major Players of Stem Cells

Table 7. Major Players of Others

Table 8. Global Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)

Table 9. Global Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Anti-Ageing Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Anti-Ageing Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Anti-Ageing Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)

Table 14. Global Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Anti-Ageing Drugs Revenue by Application (2017-2022)

Table 16. Global Anti-Ageing Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Anti-Ageing Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Anti-Ageing Drugs Sales by Company (2020-2022) & (K Units)

Table 19. Global Anti-Ageing Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Anti-Ageing Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Anti-Ageing Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Anti-Ageing Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Anti-Ageing Drugs Producing Area Distribution and Sales Area

Table 24. Players Anti-Ageing Drugs Products Offered

Table 25. Anti-Ageing Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Anti-Ageing Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Anti-Ageing Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Anti-Ageing Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Anti-Ageing Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Anti-Ageing Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Anti-Ageing Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Anti-Ageing Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Anti-Ageing Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)

Table 37. Americas Anti-Ageing Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Anti-Ageing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Anti-Ageing Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)

Table 41. Americas Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)

Table 43. Americas Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Anti-Ageing Drugs Sales by Region (2017-2022) & (K Units)

Table 45. APAC Anti-Ageing Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Anti-Ageing Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Anti-Ageing Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)

Table 49. APAC Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)

Table 51. APAC Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)

Table 53. Europe Anti-Ageing Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Anti-Ageing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Anti-Ageing Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)

Table 57. Europe Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)

Table 59. Europe Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Anti-Ageing Drugs Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Anti-Ageing Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Anti-Ageing Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Anti-Ageing Drugs Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Anti-Ageing Drugs Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Anti-Ageing Drugs

Table 69. Key Market Challenges & Risks of Anti-Ageing Drugs

Table 70. Key Industry Trends of Anti-Ageing Drugs

Table 71. Anti-Ageing Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Anti-Ageing Drugs Distributors List

Table 74. Anti-Ageing Drugs Customer List

Table 75. Global Anti-Ageing Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Anti-Ageing Drugs Sales Market Forecast by Region

Table 77. Global Anti-Ageing Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Anti-Ageing Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Anti-Ageing Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Anti-Ageing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Anti-Ageing Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Anti-Ageing Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Anti-Ageing Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Anti-Ageing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Anti-Ageing Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Anti-Ageing Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Anti-Ageing Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Anti-Ageing Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Anti-Ageing Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Anti-Ageing Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Anti-Ageing Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Anti-Ageing Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Anti-Ageing Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Anti-Ageing Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Nu Skin Basic Information, Anti-Ageing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Nu Skin Anti-Ageing Drugs Product Offered

Table 97. Nu Skin Anti-Ageing Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Nu Skin Main Business

Table 99. Nu Skin Latest Developments

Table 100. BIOTIME Basic Information, Anti-Ageing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. BIOTIME Anti-Ageing Drugs Product Offered

Table 102. BIOTIME Anti-Ageing Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. BIOTIME Main Business

Table 104. BIOTIME Latest Developments

Table 105. Elysium Health Basic Information, Anti-Ageing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. Elysium Health Anti-Ageing Drugs Product Offered

Table 107. Elysium Health Anti-Ageing Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Elysium Health Main Business

Table 109. Elysium Health Latest Developments

Table 110. La Roche-Posay Basic Information, Anti-Ageing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. La Roche-Posay Anti-Ageing Drugs Product Offered

Table 112. La Roche-Posay Anti-Ageing Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. La Roche-Posay Main Business

Table 114. La Roche-Posay Latest Developments

Table 115. DermaFix Basic Information, Anti-Ageing Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. DermaFix Anti-Ageing Drugs Product Offered

Table 117. DermaFix Anti-Ageing Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. DermaFix Main Business

Table 119. DermaFix Latest Developments

List of Figures

Figure 1. Picture of Anti-Ageing Drugs

Figure 2. Anti-Ageing Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-Ageing Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-Ageing Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-Ageing Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hormonal Therapy

Figure 10. Product Picture of Antioxidants

Figure 11. Product Picture of Enzymes

Figure 12. Product Picture of Stem Cells

Figure 13. Product Picture of Others

Figure 14. Global Anti-Ageing Drugs Sales Market Share by Type in 2021

Figure 15. Global Anti-Ageing Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Anti-Ageing Drugs Consumed in Skin

Figure 17. Global Anti-Ageing Drugs Market: Skin (2017-2022) & (K Units)

Figure 18. Anti-Ageing Drugs Consumed in Hair

Figure 19. Global Anti-Ageing Drugs Market: Hair (2017-2022) & (K Units)

Figure 20. Anti-Ageing Drugs Consumed in Others

Figure 21. Global Anti-Ageing Drugs Market: Others (2017-2022) & (K Units)

Figure 22. Global Anti-Ageing Drugs Sales Market Share by Application (2017-2022)

Figure 23. Global Anti-Ageing Drugs Revenue Market Share by Application in 2021

Figure 24. Anti-Ageing Drugs Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Anti-Ageing Drugs Revenue Market Share by Company in 2021

Figure 26. Global Anti-Ageing Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Anti-Ageing Drugs Revenue Market Share by Geographic Region in 2021

Figure 28. Global Anti-Ageing Drugs Sales Market Share by Region (2017-2022)

Figure 29. Global Anti-Ageing Drugs Revenue Market Share by Country/Region in 2021

Figure 30. Americas Anti-Ageing Drugs Sales 2017-2022 (K Units)

Figure 31. Americas Anti-Ageing Drugs Revenue 2017-2022 ($ Millions)

Figure 32. APAC Anti-Ageing Drugs Sales 2017-2022 (K Units)

Figure 33. APAC Anti-Ageing Drugs Revenue 2017-2022 ($ Millions)

Figure 34. Europe Anti-Ageing Drugs Sales 2017-2022 (K Units)

Figure 35. Europe Anti-Ageing Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Anti-Ageing Drugs Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Anti-Ageing Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Americas Anti-Ageing Drugs Sales Market Share by Country in 2021

Figure 39. Americas Anti-Ageing Drugs Revenue Market Share by Country in 2021

Figure 40. United States Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Anti-Ageing Drugs Sales Market Share by Region in 2021

Figure 45. APAC Anti-Ageing Drugs Revenue Market Share by Regions in 2021

Figure 46. China Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Anti-Ageing Drugs Sales Market Share by Country in 2021

Figure 53. Europe Anti-Ageing Drugs Revenue Market Share by Country in 2021

Figure 54. Germany Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Anti-Ageing Drugs Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Anti-Ageing Drugs Revenue Market Share by Country in 2021

Figure 61. Egypt Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Anti-Ageing Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Anti-Ageing Drugs in 2021

Figure 67. Manufacturing Process Analysis of Anti-Ageing Drugs

Figure 68. Industry Chain Structure of Anti-Ageing Drugs

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390